Jim Cramer takes the pulse of the American consumer ahead of the holidays, by looking at these three stocks.» Read More
The seven federal tax rates remain the same next year, but the amounts of income that fall into each tax bracket will increase a bit.
Jim Cramer takes a deep dive into GoPro. Is this stock the real deal, or just another gadget fad that will be gobbled up by the competition?
Art Cashin of UBS says stocks got a pop after European markets closed. Lowered growth outlook weighed on indices across the pond.
Check out which companies are making headlines after the bell Tuesday: FireEye, Potbelly, Zulily & more
Stocks drop amid report tension is brewing between ECB head Mario Draghi and his counterparts ahead of Thursday's meeting.
Wall Street is punishing Michael Kors for weaker sales growth, but it just may be that a slower but steadier pace is what Kors really needs.
A portfolio of stocks with Republican pure plays reveals GOP may gain a lot this election round.
A reduction in mall traffic means some retailers could expect lower sales this holiday shopping season, says CNBC's Jim Cramer.
Lower guidance shows Herbalife faces challenges outside the relentless attacks from activist investors, says CNBC's Jim Cramer.
Michael Kors and Priceline both reported earnings beats, but slowing growth could sour momentum traders on the stocks.
Google, Facebook and Twitter should take notes! Jim Cramer reviews the importance of storytelling on a company's stock, courtesy of Kevin Spacey.
Three commodities are on Dennis Gartman's "buy" list.
"Mad Money" host Jim Cramer speculates that this big stock could be headed higher after earnings on Tuesday.
Again chatter on the Street had everything to do with oil, after the price dropped to its lowest level in about three years.
After stocks hit a new intraday high on Monday, the CNBC "Fast Money" traders share their best plays going forward.
Some of the names on the move ahead of the open.
The "Fast Money" traders share their final trades of the day.
Here are several different approaches to rebalancing.
Jim Cramer spoke with the CEO of freshly spun-off company Halyard Health, to determine the impact of Ebola to the stock and where it's headed.
The U.S. stock market is far from a no-brainer, RiskReversal.com's Dan Nathan says.